CN | EN

Home

About

Pipeline

Distribution

News

Contact

Get in Touch

CN|EN

Shaping the future of
consumer medicines

Explore Products Learn More
Watch Video
67+
Years of Pharmaceutical Heritage
(since 1958)
#1
Ranked #1 in Anti-Hair Loss &
Minoxidil for 10 Consecutive Years
75%
Minoxidil Market
Share in China
5M+
Annual sales of
Minoxidil Foam (Bottles)
Your Reliable China Partner Exploring Global Opportunities Together

Rx&OTC

A comprehensive portfolio of prescription and OTC drugs across dermatology, allergy, and hair loss treatments.

Cosmetics

Mandi®️Functional Hair Care Series：Targeted Coverage Across Four Key Benefits

Channels

Full online and offline penetration across major e-commerce platforms, social commerce, O2O delivery, 2,000+ medical institutions, and 190,000+ retail pharmacies nationwide.
Upcoming Event

Connect with us at leading global pharma and healthcare exhibitions.

CPHI Milan 2026 — Mandi at Stand 20J13
Visit us at CPHI Milan 2026 — Stand 20J13

Development History

2001

2001

● First domestically approved 5%Minoxidil Liniment, filling acritical gap in China's hair loss treatment market.
2018

2018

● Upgraded MandiR 5%Minoxidil Liniment with room-temperature stabilization technology,solving a long-standing industry challenge andensuring storage stability.
2024

2024

● Launched second-generation Mandi 5% Minoxidil Foam,China's first and onlyapproved domesticfoam drug in thechemical drug sector.
2025

2025

● Launched Mandi Anti-Hair Loss andHair-Strengthening Shampoo, China'sfirst functional anti-hair loss shampoo containing Unoqualine

NEWS

MORE
2026-09-20
Do you need to go to the hospital if you lose a lot of hair? First, check if your hair is getting thinner and thinner
The 2023 China OTC Enterprise Brand List is announced, and Man Di has won the championship in the field of chemical medicine and skin for the first time
2026-09-20
How severe does hair loss need to be to require a hospital visit? Don't just look at how many strands have fallen out
Mandi foam agent: it is approved to market for the treatment of male alopecia and alopecia areata!
2026-9-20
What is the difference between androgenetic alopecia and normal hair loss? The key lies in three points
Mandy foam new drug conference: medical research achievements shine on the stage, building a healthy future for hair
2026-09-20
What is androgenetic alopecia? How is it distinguished from normal hair loss
Zhejiang Wansheng Pharmaceutical Hair Enterprise Research Institute, a subsidiary of Sansheng Pharmaceutical, has been selected as a provincial enterprise research institute to be recognized in Zhejiang Province in 2022
2026-09-20
Why does postpartum hair loss never seem to get better? Don't just focus on the first few months after giving birth
Targeting the growth market behind 250 million people, Mandy creates 400 million year GMV
2026-09-20
What should be done about severe postpartum hair loss? Treatment differs during breastfeeding and after weaning
Targeting the growth market behind 250 million people, Mandy creates 400 million year GMV
Get in Touch

Start Your Journey with Mandi

Comprehensive hair and skin health products and innovative pipeline to support global partners — from established consumer medicines to next-generation therapeutics.

Contact Us